Borenshtein Diana
Main achievement
Clinical Applications Manager. Cell and Gene Therapy Specialist at Miltenyi Biotec. Ph. D. in Molecular and Systems Toxicology MIT
About
Diana Borenshtein is an outstanding healthcare and life sciences professional with an impressive career in the United States of America. Holding a Doctor of Philosophy (PhD) degree from the MIT Department of Bioengineering and a master's degree from the Hebrew University of Jerusalem, she has accumulated over 15 years of experience in strategic leadership, business development, and technical sales consulting within the life sciences industry. Recently, in December 2023, she was appointed Vice President of Healthcare and Life Sciences at Kanda Software, where she leads expansion efforts in existing accounts and new business opportunities, focusing on digital solutions for biotechnology and pharmaceuticals, particularly in the field of cell and gene therapies. Throughout her career, Diana Borenshtein has held senior positions at leading biotech companies, cultivating strategic partnerships with pharmaceutical industry leaders and demonstrating a deep understanding of trends, challenges, and growth areas in life sciences. She holds prestigious certifications, such as the MIT Sloan program in Artificial Intelligence in Pharma and Biotech, as well as strategic sales courses from the Miller Heiman Group. She is fluent in English, Russian, and Hebrew, and her colleagues praise her for a rare combination of customer insights, business focus, and scientific interest, highlighting her contributions to market assessments, Voice of Customer studies, and licensing agreements. In addition to her professional achievements, Diana Borenshtein explores artistic expression through her art collection "I See You Art", inspired by shapes and colors, reminiscent of Georgia O’Keeffe's style. Although details about her personal life are not widely available publicly, her trajectory in the US, marked by elite education and multicultural adaptation, illustrates the resilience and vision of a successful woman in medicine and biotech innovation, contributing to the transformation of drug development and therapy production.
